Vennare Raymond F
Known title: DirectorCIK: 0001882090
Vennare Raymond F's purchase track record
Vennare Raymond F has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/2/2022 | AGPU | $3K | -20.4% | -67.6% | +5.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AGPU | ▼ Sell | Tax Withholding | 6,758 | $18K | 2/5/2026 | View on chart |
| AGPU | ▲ Buy | Grant | 20,000 | $0 | 12/10/2025 | View on chart |
| AGPU | ▼ Sell | Tax Withholding | 2,373 | $14K | 11/28/2025 | View on chart |
| AGPU | ▲ Buy | Grant | 124,959 | $0 | 9/9/2025 | View on chart |
| AGPU | ▲ Buy | Grant | 58,708 | $0 | 1/3/2023 | View on chart |
| AGPU | ▲ Buy | Open Market | 4,600 | $2K | 12/2/2022 | View on chart |
| AGPU | ▲ Buy | Open Market | 400 | $207 | 12/2/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 16,667 | $0 | 10/3/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 31,700 | $0 | 7/1/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 6,142 | $0 | 3/31/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 14,709 | $0 | 1/4/2022 | View on chart |
| AGPU | ▲ Buy | Grant | 4,512 | $0 | 10/1/2021 | View on chart |
| AGPU | ▲ Buy | Grant | 5,000 | $0 | 9/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Axe Compute Signs $266M in AI Contracts, Exits Cancer Business
Axe Compute has secured over $266 million in new AI infrastructure contracts since mid-August. The company is also selling its cancer business to fully transition into an AI-focused entity. These moves mark a significant strategic shift for the stock, which trades with high beta and has a wide 52-week range.
Axe Compute Signs $266M in AI Contracts, Exits Cancer Business. Axe Compute has secured over $266 million in new AI infrastructure contracts since mid-August. The company is also selling its cancer business to fully transition into an AI-focused entity. These moves mark a significant strategic shift for the stock, which trades with high beta and has a wide 52-week range.